NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in China and Expands Online Marketing in the U.S. and China
November 29 2022 - 6:50AM
Business Wire
Douyin, China’s TikTok counterpart, drives 26%
increase in DERMAdoctor sales and 258% more visitors to its online
stores during Double 11 event
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces
the expansion of its lifestyle promotional video campaigns on
TikTok and its Chinese counterpart Douyin to reach new customers
for its Avenova® and DERMAdoctor® brand products.
“We are expanding our e-commerce presence for DERMAdoctor
products in China, which is the world’s largest e-commerce market,
accounting for more than 50% of global e-commerce transactions,”
said Justin Hall, CEO of NovaBay Pharmaceuticals. “UNQ Group, our
new marketing partner in China, is running influencer videos
through its Fancy subsidiary on Douyin, while also developing
e-commerce strategies and offering integrated solutions to promote
our DERMAdoctor products in this exceptionally large market for
skincare products. Douyin is the leading short-video app in China
and our new influencer videos provide an opportunity to efficiently
reach customers among its 550 million active monthly users.
“We recently ran a successful campaign in China during the 12
days of Double 11, so named because it ends on November 11th. This
is the world’s highest-grossing online shopping festival,
generating several times more revenue than Black Friday in the U.S.
Our influencer ads during this year’s event drove year-over-year
increases of 26% in sales and 258% in total visitors to our online
DERMAdoctor stores in China,” he added. “Earlier this year, we
engaged Doumai, a leading e-commerce solution provider, to refresh
our DERMAdoctor e-commerce store on TMall, the Chinese counterpart
to Amazon in China. I’m pleased to say that our online store has
gained 15,000 followers, with more than 30,000 consumers so far
placing DERMAdoctor product orders through Tmall.”
“We are excited to be working with NovaBay and promoting
DERMAdoctor’s skincare products, which align with our corporate
mission of promoting quality and interesting products that lead to
a healthy and beautiful life,” said Mr. Wang Yong, Chairman of UNQ
Group.
NovaBay is promoting its products in the U.S. through TikTok,
which is among the world’s most powerful forces in digital
advertising, particularly in reaching young consumers. TikTok has
more than 1 billion users worldwide and is on track to more than
double its 2023 ad revenue versus the prior year. The Company’s
fun, lifestyle videos on TikTok are proving highly effective in
creating brand awareness and driving sales on online platforms like
Amazon. For instance, NovaBay is running a fun ad to remind
customers to use Avenova Antimicrobial Lid & Lash Spray before
putting on mascara and recently teamed with a physician partner for
a short-form video message about managing blepharitis.
About UNQ Group:
UNQ Group (UNQ Holdings Limited (Stock Code: 2177. HK, Main
Board) and its subsidiaries), is a leading brand e-commerce retail
and wholesale solutions provider in China, strategically focused on
fast-moving consumer goods, consisting of, among others, personal
care products, beauty products, health products and others. UNQ
Group provides brand analysis, store operations, digital marketing,
logistics management and customer service based e-commerce
solutions for brands in B2C and B2B models. UNQ Group has also
established long-term partnerships with many international
brands.
About NovaBay Pharmaceuticals, Inc.:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that
develops and sells scientifically created and clinically proven
eyecare and skincare products. Avenova® is the most prescribed
antimicrobial lid and lash spray and DERMAdoctor® is a premium
skincare brand offering more than 30 dermatologist-developed
skincare products sold through traditional domestic retailers,
digital beauty channels and international distributors.
NovaBay Pharmaceuticals Forward-Looking Statements
This press release contains “forward-looking statements” within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including, but not limited to, statements that are based
upon management’s current expectations, assumptions, estimates,
projections and beliefs. These statements include, but are not
limited to, statements regarding current and future product
offerings, marketing efforts, and any future revenue that may
result from selling such products, as well as generally the
Company’s expected future financial results. These statements
involve known and unknown risks, uncertainties and other factors
that may cause actual results or achievements to be materially
different and adverse from those expressed in or implied by the
forward-looking statements. New risks and uncertainties may emerge
from time to time, and it is not possible to predict all risks and
uncertainties. Other risks relating to NovaBay’s business,
including risks that could cause results to differ materially from
those projected in the forward-looking statements in this press
release, are detailed in NovaBay’s latest Form 10-Q/K filings with
the SEC, especially under the heading “Risk Factors,” and in the
Preliminary Proxy Statement filed by NovaBay with the SEC,
especially under the heading “Proposal Two: The Reverse Stock Split
Proposal — Risks Relating to the Reverse Stock Split.” The
forward-looking statements in this press release speak only as of
this date, and NovaBay disclaims any intent or obligation to revise
or update publicly any forward-looking statement except as required
by law.
Socialize and Stay Informed on
NovaBay’s Progress
Like us on Facebook Follow us on Twitter Connect with NovaBay on
LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221129005439/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Sep 2023 to Sep 2024